Hwang requests Science retraction

Turmoil swirls around researcher after co-author says paper on human cloning was based on fabrications

Written byStephen Pincock
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Science said today (December 16) that Woo-suk Hwang, the Korean cloning researcher, has requested a retraction of a headline-grabbing paper on patient-specific human stem cells. The announcement follows a call for a retraction by co-author Gerald Schatten of the University of Pittsburgh and reports yesterday by Korean media that Hwang had admitted to a colleague that the paper was based on fabricated data.

In an interview yesterday (December 15) on the Korean national broadcaster MBC, Hwang's research collaborator and co-author, Sung Il Roh, said no patient-specific stem cells exist. "When I visited Hwang in hospital early this morning (Thursday), Hwang said there were no cloned embryonic stem cells at all," said Roh, head of infertility clinic Mizmedi Women's Hospital, in an interview quoted in the Korea Times.

"I have waited, thinking that Hwang would announce everything himself since only he is eligible to put a halt to all the suspicions,'' ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform